Synthesis and cardiotonic activity of novel pyrimidine derivatives: Crystallographic and quantum chemical studies

Journal of Medicinal Chemistry

Volumn 39, Issue 19, 1996, Pages 3671-3683

  Dorigo, Paola ^a   Fraccarollo, Daniela ^a   Santostasi, Giovanni ^a   Maragno, Ildebrando ^a   Floreani, Maura ^a   Borea, Pier Andrea ^b   Mosti, Luisa ^c   Sansebastiano, Laura ^c   Fossa, Paola ^c   Orsini, Fulvia ^d   Benetollo, Franco ^e   Bombieri, Gabriella ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 BENZYL 2 (DIMETHYLAMINO) 5 PYRIMIDINECARBOXYLIC ACID; 4 BENZYL 2 (DIMETHYLAMINO) 5 PYRIMIDINECARBOXYLIC ACID METHYL ESTER; INOTROPIC AGENT; MILRINONE; PYRIMIDINE; RESERPINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CRYSTALLOGRAPHY; GUINEA PIG; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; INOTROPISM; MORTALITY; NONHUMAN; QUANTUM CHEMISTRY; STRUCTURE ACTIVITY RELATION; X RAY ANALYSIS;

EID: 9544257263     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9508649     Document Type: Article

References (57)

1. Francis, G. S. The Relationship of the Sympathetic Nervous System and the Renin-Angiotensin System in Congestive Heart Failure. Am. Heart J. 1989, 118, 642-648.
2. Newman, W. H.; Grossman, S. J.; Frankis, M. B.; Webb, J. G. Increased Myocardial Adenosine Release in Heart Failure. J. Mol. Cell. Cardiol. 1984, 16, 577-580.
3. Belardinelli, L.; West, A.; Crampton, R.; Berne, R. M. Chronotropic and Dromotropic Actions of Adenosine. In Regulatory Function of Adenosine; Berne, R. M., Rall, T. W., Rubio, R., Eds.; Nihoff: Boston, 1983; pp 378-398.
4. Endoh, M.; Maruyama, M.; Taira, N. Adenosine-Induced Changes in Rate of Beating and Cyclic Nucleotide Levels in Rat Atria: Modifications by Islet-Activating Protein. In Physiology and Pharmacology of Adenine Derivatives; Daly, J. W., Kuroda, Y., Phillis, J. W., Schmizu, H., VI, Eds.; Raven Press: New York, 1983; pp 127-141.
5. Pelleg, A.; Mitsouka, T.; Michelson, E. L. Adenosine Mediates the Negative Chrontropic Actions of Adenosine 5′-Triphosphate in Canine Sinus Node. J. Pharmacol. Exp. Ther. 1987, 242, 791-798.
6. Belardinelli, L.; Isenberg, G. Isolated Atria Myocites: Adenogine and Acetylcholine Increase Potassium Conductance. Am. J. Physiol. 1983, 244, H734-H737.
7. Bohm, M.; Bruckner, R.; Hackabarth, I.; Haubitz, B.; Linhart, R.; Meyer, W.; Schmidt, B.; Schmidz, W.; Scholz, H. Adenosine Inhibition of Catecholamine-Induced Increase in Force of Contraction in Guinea Pig Atria and Ventricular Heart Preparation. Evidence against a Cyclic AMP- and Cyclic GMP- Dependent Effect. J. Pharmacol. Exp. Ther. 1984, 230, 483-492.
8. Cerbai, E.; Klockner, U.; Isenberg, G. Ca-Antagonistic Effect of Adenosine in Guinea Pig Atrial Cells. Am. J. Physiol. 1988, 255, H872-H878.
9. Prostan, M.; Varagic, V. M. Interactions of 5-N-Ethyl-carboxamide Adenosine (NECA), Aminophylline and Dipropil-phenylxanthine (XAC) on the Isolated Guinea Pig Atria. Arch, Int. Pharmacodyn. 1988, 294, 137-148.
10. Jochem, G.; Nawrath, H. Adenosine Activates a Potassium Conductance in Atrial Heart Muscle. Experientia 1983, 39, 1347-1349.
11. Visentin, S.; Wu, S. N.; Belardinelli, L. Adenosine-Induced Changes in Atrial Action Potential: Contribution of Ca and K Channels. Am. J. Physiol. 1990, 258, H1070-H1078.
12. Lubbe, W. F.; Podzuweit, T.; Opie, L. H. Potential Arrhythmogenic Role of Cyclic Monophosphate (AMP) and Cytosolic Calcium Overload: Implications for Prophylactic Effects of Beta-Blockers in Myocardial Infarction and Proarrhythmic Effects of Phosphodiesterase Inhibitors. J. Am. Coll. Cardiol. 1992, 19, 1622-1633.
13. Packer, M. Vasodilator and Inotropic Drugs for the Treatment of Chronic Heart Failure: Distinguishing Hype from Hope. J. Am. Coll. Cardiol. 1988, 12, 1299-1317.
14. Packer, M.; Carver, J. R.; Rodeheffer, R. J.; Ivanhoe, R. J.; Dibianco, R.; Zeldis, S. M.; Hendrix, G. H.; Bommer, W. J.; Elkayam, D.; Kukin, M. L.; Mallis, G. I.; Sollano, J. A.; Shannon, J.; Tandon, P. K.; De Metes, D. L. Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure. N. Engl. J. Med. 1991, 325, 1468-1475.
15. Dorigo, P.; Maragno, I. Interaction of Amrinone with Endogenous Adenosine in Guinea Pig Atria. Br. J. Pharmacol. 1986, 32, 623-629.
16. Earl, C. Q.; Linden, J.; Weglicki, W. B. Biochemical Mechanism for the Inotropic Effect of the Cardiotonic Drug Milrinone. J. Cardiovasc. Pharmacol. 1986, 8, 864-871.
17. 1 Adenosine Receptor Antagonist and Functionally Blocks the Inhibitory Regular Gi. Mol. Pharmacol. 1988, 33, 441-448.
18. Dorigo, P.; Gaion, R. M.; Maragno, I. Involvement of Purine Compounds in the Inotropic Action of Milrinone. Cardiovasc. Drugs Ther. 1990, 4/2, 509-514.
19. 1 Adenosine Receptors and m-Cholinoceptors in Human Myocardium. Naunyn-Schmiedeberg's Arch. Pharmacol. 1990, 341, 577-585.
20. Mosti, L.; Menozzi, G.; Schenone, P.; Dorigo, P.; Gaion, R. M.; Benetollo, F.; Bombieri, G. Synthesis and Cardiotonic Activity of Esters of 2-Substituted 5-Cyano-1,6-dihydro-6-oxo-3-pyridin-ecarboxylic Acids. Crystal Structure of 2-Methyl, 2-t-Butyl and 2-Phenyl Esters. Eur. J. Med. Chem. 1989, 24, 517-529.
21. Mosti, L.; Menozzi, G.; Schenone, P.; Dorigo, P.; Gaion, R. M.; Belluco, P. Synthesis and Cardiotonic Activity of 3-Substituted 5-Cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylic Acids and Their Methyl or Ethyl Esters. Farmaco 1992, 47 (4), 427-437.
22. Mosti, L.; Schenone, P.; Iester, M.; Dorigo, P.; Gaion, R. M.; Fraccarollo, D. Synthesis and Cardiotonic Activity of Esters of 2-Substituted 5-Acetyl-1,6-dihydro-6-oxo-3-pyridinecarboxylic Acids. Eur. J. Med. Chem. 1993, 28, 853-858.
23. Dorigo, P.; Gaion, R. M.; Belluco, P.; Borea, P. A.; Guerra, L.; Mosti, L.; Floreani, M.; Carpenedo, F. Antagonism toward Endogenous Adenosine and Inhibition of cGI-PDE in the Effects of Amrinone, Milrinone and Related Analogues. Gen. Pharmacol. 1992, 23, 535-541.
24. Dorigo, P.; Gaion, R. M.; Belluco, P.; Fraccarollo, D.; Maragno, I.; Bombieri, G.; Benetollo, F.; Mosti, L.; Orsini, F. A Pharmacological, Crystallographic and Quantum Chemical Study of New Inotropic Agents. J. Med. Chem. 1993, 36, 2475-2484.
25. Dorigo, P.; Fraccarollo, D.; Santostasi, G.; Gaion, R. M.; Maragno, I.; Floreani, M.; Carpenedo, F.; Iester, M.; Mosti, L.; Schenone, P. Pharmacological Characterization of a New Milrinone Analogue. Farmaco 1994, 49 (1), 19-23.
26. Orsini, F.; Benetollo, F.; Bombieri, G.; Mosti, L. Cardiotonic Agents: a Crystallographic and Quantum-Chemical Study of Ethyl 5-Cyano-1,6-dihydro-2-isopropyl-6-oxo-3-pyridinecarboxylate and Related Compounds. Eur. J. Med. 1990, 25, 425-429.
27. Orsini, F.; Benetollo, F.; Bombieri, G.; Mosti, L. Conformational Analysis and Inotropic Activity of 2-Substituted 5-Cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylates. II. Eur. J. Med. Chem. 1993, 28, 637-641.
28. Lesher, G. Y.; Singh, B. Pyridinyl-2-pyrimidinamines Useful as Cardiotonics and Preparation thereof. U.S. PCT Int. Appl. WO 85/00604, Feb. 14, 1985; Chem. Abstr. 1986, 103, P6364p.
29. Schenone, P.; Sansebastiano, L.; Mosti, L. Reaction of 2-Dimethylaminomethylene-1,3-diones with Dinucleophiles. VIII. Synthesis of Ethyl and Methyl 2,4-Disubstituted 5-Pyrimidinecarboxylates. J. Heterocycl. Chem. 1990, 27, 295-305.
30. Sansebastiano, L.; Mosti, L.; Menozzi, G.; Schenone, P.; Muratore, O.; Petta, A.; Debbia, E.; Pesce, A.; Schito, G. C. Synthesis, Antiviral (HSV-1) and Antimycotic Activities of Ethyl or Methyl 2,4-Disubstituted 5-Pyrimidinecarboxylates, 2,4-Disubstituted 5-Pyrimidinecarboxylic Acids and 2,4-Disubstituted Pyrimidines. Farmaco 1993, 48 (3), 335-355.
31. Panizzi, L. Ricerche su β-Dialdeidi. Nota I. Carbetossimalondialdeide. Gazz. Chim. Ital. 1946, 76, 56-65.
32. Menozzi, G.; Mosti, L.; Schenone, P. Reaction of 2-Dimethylaminomethylene-1,3-diones with Dinucleophiles. VI. Synthesis of Ethyl or Methyl 1,5-Disubstituted 1H-Pyrazole-4-carboxylates. J. Heterocycl. Chem. 1987, 24, 1669-1675.
33. Menozzi, G.; Mosti, L.; Schenone, P.; Donnoli, D.; Schiariti, F.; Marmo, E. 1-Phenyl-1H-pyrazole Derivatives with Antiinflammatory, Analgesic and Antipyretic Activities. Farmaco 1990, 45 (2), 167-186.
34. Jones, R. G. The Synthesis of Ethyl Ethoxymethyleneoxalacetate and Related Compounds. J. Am. Chem. Soc. 1951, 73, 3684-3686.
35. Overberger, C. G.; Kogon, I. C. Monomer Synthesis. Methylation of 2-Aminopyrimidine. J. Am. Chem. Soc. 1954, 76, 1065-1068.
36. Overberger, C. G.; Kogon, I. C. Monomer Synthesis. X. The Preparation and Polymerization of 4-Vinylpyrimidine and 2-N,N-Dimethylamino-4-vinylpyrimidine. J. Am. Chem. Soc. 1954, 76, 1879-1883.
37. Bennett, G. B.; Mason, R. B.; Alden, L. J.; Roach, J. B., Jr. Synthesis and Antiinflammatory Activity of Trisubstituted Pyrimidines and Triazines. J. Med. Chem. 1978, 21, 623-628.
38. Endoh, M.; Yanagisawa, T.; Taira, N.; Blinks, J. Effects of New Inotropic Agents on Cyclic Nucleotide Metabolism and Calcium Transient in Canine Muscle. Circulation 1986, 73 (Suppl. III), 117-133.
39. Endoh, M. Correlation of Cyclic AMP and Cyclic GMP Levels with Changes in Contractile Force of Dog Ventricular Myocardium During Cholinergic Antagonism of Positive Actions of Histamine, Glucagon, Theophylline and Papaverine. Jpn. J. Pharmacol. 1979, 29, 855-864.
40. Skomedal, T.; Schiander, I.; Aass, H.; Osnes, J. B. Properties of the Inotropic Response in Rat Papillary Muscle to the Dihydropyridine "Ca-Channel Activator" BAYK8644. Pharmacol. Toxicol. 1988, 63, 20-25.
41. Weishaar, R. E.; Kobylarz-Singer, D. L.; Steffen, R. P.; Kaplan, A. R. Subclasses of Cyclic AMP Specific Phosphodiesterase in Left Ventricular Muscle and Their Involvement in Regulating Myocardial Contractility. Circ. Res. 1987, 61, 539-547.
42. 2 Adenosine Receptors in Guinea Pig Ventricular Cardiomyocytes. J. Mol. Cell. Cardiol. 1994, 26, 403-414.
43. 2 Receptors. In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology; Belardinelli, L., Pelleg, A., Eds.; Kluwer Academic Publishers: Boston, Dordrecht, London, 1995; pp 27-37.
44. Temma, K.; Akera, T.; Brody, T. M.; Mannian, A. A. Hydroxylated Chloropromazine Metabolites: Positive Inotropic Action and the Release of Catecholamines. Mol. Pharmacol. 1977, 13, 1076-1085.
45. Thomson, W. J.; Terasaki, W. L.; Epstein, P. M.; Strada, S. J. Assay of Cyclic Nucleotide Phosphodiesterase and Resolution of Multiple Molecular Forms of the Enzyme. Adv. Cyclic Nucl. Res. 1979, 10, 69-72.
46. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein Measurement with the Folin Phenol Reagent. J. Biol. Chem. 1951, 193, 265-275.
47. Thompson, W. J.; Brooker, G.; Appleman, M. M. Assay of Cyclic Nucleotide Phosphodiesterase with Radioactive Substrates. Methods Enzymol. 1974, 38, 205-214.
48. 3H]phenylxanthine. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 5547-5551.
49. Schild, H. O. pA, a new scale for measurement of drug antagonist. Br. J. Pharmacol. 1947, 2, 189-193.
50. Molecular Advanced Design (1992) Acquitaine System, Departement Scientifique, Tour Elf, 2 Place de la Coupole, Cedex 45, 92078 Paris La Defence, France.
51. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. P. AM1: A New General Purpose Quantum Mechanical Molecular Model. J. Am. Chem. Soc. 1985, 107, 3902.
52. Quantum Chemistry Programm Exchange no. 527, Indiana University, Bloomington, IN.
53. 50 has been used to display the structures of 28 and SF40 (generated from AM1-optimized coordinates) and to orient them.
54. 50 has been used to display and fit the structures of 28 and SF40 (generated from AMl-optimized coordinates). Four atoms for each molecule were included in the fitting procedure: This uses a classical least-squares algorithm which considers two sets of 3D-coordinates, the second one being modified to fit as closely as possible to the first one.
55. Sheldrick, G. M. SHELXS-86. Program for Crystal Structure Determination. Acta Crystallogr. 1990, A46, 467-473.
56. Sheldrick, G. M. SHELXL-93. Program for the Refinement of Crystal Structure; University of Göttingen: Germany, 1993.
57. Johnson, C. K. ORTEPII. Report ORNL-5138; Oak Ridge National Laboratory: Tennessee, 1976.